Asset Comparison and Correlation
|Celgene Corp. vs Seattle Genetics Inc.|
Given investment horizon of 30 days, Celgene Corporation is expected to generate 0.79 times more return on investment than Seattle. However, Celgene Corporation is 1.26 times less risky than Seattle. It trades about 0.11 of its potential returns per unit of risk. Seattle Genetics Inc is currently generating about -0.12 per unit of risk. If you would invest 12,034 in Celgene Corporation on April 25, 2013 and sell it today you would earn a total of 224.00 from holding Celgene Corporation or generate 1.86% return on investment over 30 days.
95% of all equities and portfolios perform better than Celgene Corporation. Compared with the overall equity markets, risk-adjusted returns on investments in Celgene Corporation are ranked lower than 5 (%) of all global equities and portfolios over the last 30 days.
Match-ups for Celgene
Over the last 30 days Seattle Genetics Inc has generated negative risk-adjusted returns adding no value to investors with long positions.
Match-ups for Seattle